Merck & Co., Inc. (NYSE:MRK) stock is presently standing at about $59.92 and lots of equity research firms seem to have a target price set on the stock. And a quick view of analyst notes show that 8 are rating the stock a buy while 2 rate MRK a strong buy. There are 11 equity research firms advocating a Hold and 0 consider it Sell.

Jefferies analysts provided their view on Merck & Co., Inc. (NYSE:MRK) recently. The rating firm issued a Underperform rating to this company in a research note released on Dec 19, 2016. BofA/Merrill analysts disclosed their opinion on Merck & Co., Inc. (NYSE:MRK) recently. The rating firm gave a Buy rating to this stock in a research note published on Oct 13, 2016. According to a research note disclosed on Aug 08, 2016, analysts at Credit Suisse have upped their rating on these shares from Neutral to Outperform.

Merck & Co., Inc. (NYSE:MRK) Transactions Roundup

Several insiders were part of recent insider activity for the stock. Its Chairman, President & CEO FRAZIER KENNETH C sold 140,000 company shares for $9104000.2, in a transaction on 2016-11-10. Following the transaction, the Chairman, President & CEO is left with a stake of 9104.2 shares, currently valued at $545524. Meanwhile, EVP Strat Comm, Gl Pub Policy Gerberding Julie L. sold 85,523 shares worth $5133000.09, through a transaction dated 2016-11-07. Following the completion of the transaction, the insider is left with a stake of 39,115 shares, amounting $2343770.8. MRK Director LAZARUS ROCHELLE B also sold 20,000 shares, at a stock price of $59.06. This transaction occurred on 2016-11-02 totals $1181000.2. After this transaction, the insider’s stake stands at 6,351 shares, with a market value of $380552.

Executives hold 0.09 percent of the stock. Kenneth C. Frazier is one of the biggest insider owners in Merck & Co., Inc. (NYSE:MRK), according to U.S. Securities and Exchange Commission (SEC) filings. The insider owns 508,877 shares which have current market value of around $30491909.84.Peter S. Kim is another major inside shareholder in the company. The insider owns 189,609 shares as of less than 0.1%, currently worth $11361371.28. Joseph C. Connors is ranked as third insider holder of the stock. This insider holds 165,410 shares with a market value around $9911367.2 as of recent close.

Merck & Co., Inc. (NYSE:MRK) Earnings Outlook

In Merck & Co., Inc. (NYSE:MRK)’s latest quarter, EPS moved to $1.07 from $0.93 in preceding quarter and revenues reached at $10,536.00M compared to $9,844.00M. Analysts had expected Merck & Co., Inc. (NYSE:MRK) to post net income of about $0.99 per share on $10,177.10M in revenue. Looking ahead, analysts on average predict that earnings for the current quarter would come in in the range of $0.85 to $0.97. That is compared with the $0.93 in EPS it reported during the same period a year ago.